table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 mild to moderateCOVID-19 severe or critically
lopinavir/ritonavir SOLIDARITY ... Nojomi Ader ... RECOVERY ELACOI ... REMAP-CAP ... Cao

2 studies excluded by filtering options 0

5210 Ye et al., 2020 2990excludednot a RCTrisk of bias not avaialble
6751 Chen_lopi_rito, 2020 1134not a RCThigh risk of bias

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons